Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoldering Multiple Myeloma 1

Interventions

Cyclophosphamide 20 fludarabine phosphate 14 Peripheral Blood Stem Cell Transplantation 13 Dexamethasone 13 Cyclosporine 12 Whole-Body Irradiation 11 fludarabine 10 Exercise 10 Antilymphocyte Serum 10 Melphalan 9 Busulfan 9 Blood Specimen Collection 9 Mycophenolic Acid 8 Therapeutics 7 Filgrastim 7 Bortezomib 7 Standard of Care 6 Radiotherapy 6 Behavior Therapy 6 Acupuncture Therapy 6 pomalidomide 5 Specimen Handling 5 Palliative Care 5 Methotrexate 5 Granulocyte Colony-Stimulating Factor 5 Etoposide 5 Educational Status 5 daratumumab 4 Surveys and Questionnaires 4 Stem Cell Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Myelography × Plasma cell × Clear all

NCT04144387 2024-03-06

CARRISMM

Intergroupe Francophone du Myelome

Phase NA Active not recruiting

Smoldering Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡